Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia
Psychiatry and Clinical Neurosciences · 2026-08 · 80 (8) · 703-704
DOI: 10.1111/pcn.70089 ↗At a glance
Journal article in Psychiatry and Clinical Neurosciences, published online on 2026-05-28. Written by Yuki Matsuda and 1 co-authors. Institution: Department of Development and Education of Clinical Research, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Major MEDLINE topics: Tardive Dyskinesia, Cholinergic Antagonists, Vesicular Monoamine Transport Proteins. Cited 1 times so far (Crossref); 7 references. The full text is freely available in PubMed Central.
Abstract (original language)
This article relates to Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Development and Education of Clinical Research, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
- Centre for Translational Research, Fujita Health University, Toyoake, Aichi, Japan.
Cite
APA
Matsuda, Y., & Suzuki, Y. (2026). Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia. Psychiatry and Clinical Neurosciences, 80(8), 703-704. https://doi.org/10.1111/pcn.70089
Vancouver
Matsuda Y, Suzuki Y. Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia. Psychiatry and Clinical Neurosciences. 2026;80(8):703-704. doi:10.1111/pcn.70089
BibTeX
@article{Matsuda2026,
author = {Matsuda, Yuki and Suzuki, Yuta},
title = {Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia},
journal = {Psychiatry and Clinical Neurosciences},
year = {2026},
volume = {80},
number = {8},
pages = {703--704},
doi = {10.1111/pcn.70089}
}
EUVIMED